Antidepressant

Stability Hygroscopic Applications A possible metabolite of Trazodone-HCl (T718500).

Applications Serotonin reuptake inhibitor. Antidepressant; antiobsessional agent. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Peters, M.D., et al.: Clin. Pharm., 9, 165 (1990), Adamczyk, M., et al.: Ther. Drug Monit., 17, 371 (1995), Poolsup, N., et al.: J. Clin. Pharm. Ther., 25, 197 (2000), Bose, D., et al.: J. Pharmacol. Toxicol. Methods, 52, 323 (2005),

Applications The S-(+) enantiomer of Mecamylamine (M202600), a noncompetitive neuronal nicotinic receptor modulator antagonist with antidepressant activity. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Fryer, J., et al.: J. Pharmacol. Exp. Ther., 288, 88 (1999), Slemmer, J., et al.: J. Pharmacol. Exp. Ther., 295, 321 (2000), Young, J., et al.: Clin. Ther., 23, 532 (2001),

Applications A labelled selective serotonin reuptake inhibitor (SSRI) used as an anti-depressant. References Claassen, V., et al.: Br. J. Pharmacol., 60, 505 (1977), Koran, L.M., et al.: J. Clin. Psychopharmacol., 16, 121 (1996), Ware, M.R., et al.: J. Clin. Psychiatry, 58, Suppl. 5, 15 (1997), Inazu, M., et al.: Neurochem. Int., 39, 39 (2001)

Applications Vigabatrin is a novel anti-epileptic drug. Antidepressant; antipsychotic; anxiolytic. References Vajda, F., et al.: Clin. Neurosci., 7, 88 (2000), Beghi, E., et al.: Lancet. Neurol., 3, 618 (2004), Sagirli, O., et al.: J. Pharmaceut. Biomed., 42, 618 (2006),

Applications N-Desmethyl Terbinafine Hydrochloride is a metabolite of Terbinafine (T107500), an orally active, antimycotic allylamine related to naftifine. References Humbert, H., et al.: Pharam. Drug Dispos., 19, 417 (1998); Vickers, A., et al.: Drug Metab. Dispos., 27, 1029 (1999); Iverson, S., et al.: Chem. Res. Toxicol., 14, 175 (2001)

Stability Hygroscopic Applications N-Methyl Fluoxetine hydrochloride is an impurity of Fluoxetine (HCl: F597100), a long-acting serotonin uptake inhibitor that is used to treat depression. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Gram, L.: New. Engl. J. Med., 331, 1354 (1994); Naranjo, C., et al.: Clin. Pharmacol. Ther., 47, 490 (1990); Thase, M., et al.: J. Clin. Psych., 58, 16 (1997)

Applications A labelled metabolite of Fluoxetine (F597100), a selective serotonin reuptake inhibitor which is used as an antidepressant. References Wong, D., et al.: J. Pharmacol. Exp. Ther., 193, 804 (1975), Thorsen, T., et al.: J. Cancer Clin. Oncol., 18, 333 (1982), Howell, A., et al.: Lancet, 365, 60 (2005),

Applications 4’-(Trifluoromethyl)valerophenone(E)-O-2-(2-aminoethyl) Oxime Maleate is an impurity in the synthesis of Fluvoxamine (F603500), a selective serotonin reuptake inhibitor (SSRI) used as an anti-depressant. Antiobsessional. References Claassen, V., et al.: Br. J. Pharmacol., 60, 505 (1977), Koran, L.M., et al.: J. Clin. Psychopharmacol., 16, 121 (1996), Ware, M.R., et al.: J. Clin. Psychiatry, 58, Suppl. 5, 15 (1997), Inazu, M., et al.: Neurochem. Int., 39, 39 (2001)

Applications Vortioxetine can be used in biological study of effectiveness of long term vortioxetine treatment of patients with major depressive disorder. References Vieta, E., et al.: Eur Neuropsychopharm (2017)

Applications Hydrochloride salt of rac N-Demethyl Dapoxetine, the racemic metabolite of Dapoxetine (D185700). Selective serotonin reuptake inhibitor antidepressant. References Wong, D., et al.: Life Sci., 57, 411 (1995), Sorbera, L., et al.: Drugs Future, 29, 1201 (2004), Cipriani, A., et al.: Lancet, 373, 746 (2009), Katzman, M., et al.: CNS Drug, 23, 103 (2009),

Applications rac-cis-N-Desmethyl Sertraline-d3 hydrochloride is a labelled metabolite of rac-cis-N-Desmethyl sertraline hydrochloride (D292100). N-Desmethyl sertraline is significantly less active analogue as compared to the methylated compound, sertraline. References Welch, W.M., et al.: J. Med. Chem. 27, 1508 (1984)

Applications Desmethylnortriptyline is a metabolite of Nortriptyline which is used in the treatment of depression and migraines. References Cheng, F., et al.: J. Brazil Chem. Soc., 19, 35 (2008)

Stability Light Sensitive Applications Crocin, is a natural carotenoid derived the flowers crocus and gardenia. Crocin has been shown to be a potent antioxidant. It has also been shown to have an antiproliferative action against cancer cells in vitro, and also possessing possible antidepressant properties. References Zheng, Y. Q., et al.: Brain Res., 1138, 86 (2006); Hosseinzadeh, H., et al.: PTR, 24 (5), 726 (2010); Ochiai, T., et al.: Biochim. Biophys. Acta., 1770(4), 578 (2006);

Applications (±)-Venlafaxine-d6 HCl (N,N-dimethyl-d6) (CAS# 1062606-12-5) is a useful isotopically labeled research compound.

Applications Methyl 1,4-Benzodioxan-2-carboxylate is an intermediate used to prepare 2,3-dihydrobenzo[b|[1,4|dioxin- and indolealkylamine derivatives as potential antidepressants. References Wang, S., et al.: Archiv der Pharmazie (Weinheim, Germany), 347, 32 (2014); Wang, S., et al.: Bioorg. Med. Chem. Lettt., 24, 1766 (2014)

Applications A metabolite of Clomipramine. References McTavish, D., et al.: Drugs, 39, 136 (1990), Chauret, N., et al.: Drug Metab. Dispos., 25, 1130 (1997), Gex-Fabry, M., et al.: Ther. Drug Monit., 22, 701 (2000), Herrera, D., et al.: J. Clin. Pharmacol., 40, 1488 (2000),

Applications Fluvoxamine impurity.

Applications Labelled S-(-)-Sulpiride (S689140). Dopamine D2 and D3-receptor antagonist. Antipsychotic; antidepressant; antiemetic. References Pitre, D., et al.: Anal. Profiles Drug Subs., 17, 607 (1988), Wagstaff, A.J., et al.: CNS Drugs, 2, 313 (1994),

Applications 2-Hydroxydesipramine Dihydrochloride is a metabolite of Desipramine (D290050), a tricyclic antidepressant that is a more potent inhibitor of the norepinephrine transporter than the serotonin transporter. References De Jongh, G.D., et al.: Drug Metab. Dispos., 2, 48 (1981); Suckow, R.F., et al.: J. Pharm. Sci., 73, 1745 (1984); Fraser, A.D., et al.: J. Anal. Toxicol., 11,168 (1987); Checkley, S.A, et al.: Br. J. Psychiatry, 138. 248 (1981); Zhu, M.Y., et al.: J. Neurochem., 70, 1547 (1998); Okugawa, G., et al.: J. Neuroindocrinol., 11, 887 (1999); Torres, G.E., et al.: Nat. Rev. Neurosci., 4, 13 (2003)